Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 10, 2024
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
Omar Soler-Cedeño, Hannah Alton, Guo-Hua Bi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 21, 2020
Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates
Lisa M Wooldridge, Lipin Ji, Yingpeng Liu, et al.
Psychopharmacology
|
November 18, 2025
Effects of the neutral CB1 receptor antagonist AM6527 on spontaneous, consummatory, and motivated behavior in mice
Alev Ecevitoglu, Quilla C Flanagan-Burt, Matthew H Zhang, et al.
Journal of Human Lactation : Official Journal of International Lactation Consultant Association
|
March 3, 2021
Maternal Dietary Fatty Acids and Their Relationship to Derived Endocannabinoids in Human Milk
Adriana V Gaitán, JodiAnne T Wood, Yingpeng Liu, et al.
Drug and Alcohol Dependence
|
July 4, 2026
Cannabinoid (CB) 1 receptor antagonists block fentanyl conditioned place preference but not fentanyl antinociception
Devin Morrisson, Evan C Smith, Dalal Alkhelb, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 27, 2017
Cannabinoid CB<sub>1</sub> Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors
Michael Z Leonard, Shakiru O Alapafuja, Lipin Ji, et al.
Cannabis and Cannabinoid Research
|
December 22, 2021
Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression
Beth M Wiese, Erika Liktor-Busa, Sarah A Couture, et al.
Cannabis and Cannabinoid Research
|
May 17, 2021
Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression
Beth M Wiese, Erika Liktor-Busa, Aidan Levine, et al.
ACS Medicinal Chemistry Letters
|
June 19, 2024
Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2
Spyros P Nikas, Lipin Ji, Yingpeng Liu, et al.
The Journal of Biological Chemistry
|
February 5, 2015
13-Methylarachidonic acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase
Shalley N Kudalkar, Spyros P Nikas, Philip J Kingsley, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 10, 2024
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects
Omar Soler-Cedeño, Hannah Alton, Guo-Hua Bi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 21, 2020
Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates
Lisa M Wooldridge, Lipin Ji, Yingpeng Liu, et al.
Psychopharmacology
|
November 18, 2025
Effects of the neutral CB1 receptor antagonist AM6527 on spontaneous, consummatory, and motivated behavior in mice
Alev Ecevitoglu, Quilla C Flanagan-Burt, Matthew H Zhang, et al.
Journal of Human Lactation : Official Journal of International Lactation Consultant Association
|
March 3, 2021
Maternal Dietary Fatty Acids and Their Relationship to Derived Endocannabinoids in Human Milk
Adriana V Gaitán, JodiAnne T Wood, Yingpeng Liu, et al.
Drug and Alcohol Dependence
|
July 4, 2026
Cannabinoid (CB) 1 receptor antagonists block fentanyl conditioned place preference but not fentanyl antinociception
Devin Morrisson, Evan C Smith, Dalal Alkhelb, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 27, 2017
Cannabinoid CB<sub>1</sub> Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors
Michael Z Leonard, Shakiru O Alapafuja, Lipin Ji, et al.
Cannabis and Cannabinoid Research
|
December 22, 2021
Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression
Beth M Wiese, Erika Liktor-Busa, Sarah A Couture, et al.
Cannabis and Cannabinoid Research
|
May 17, 2021
Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression
Beth M Wiese, Erika Liktor-Busa, Aidan Levine, et al.
ACS Medicinal Chemistry Letters
|
June 19, 2024
Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2
Spyros P Nikas, Lipin Ji, Yingpeng Liu, et al.
The Journal of Biological Chemistry
|
February 5, 2015
13-Methylarachidonic acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase
Shalley N Kudalkar, Spyros P Nikas, Philip J Kingsley, et al.
Page
of 2